SHIFA BIOMEDICAL CORP has a total of 32 patent applications. It decreased the IP activity by 87.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are INTERNATIONAL SOC FOR DRUG DEVELOPMENT S R L, VITA CIENTIFICA S L and KRKA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Canada | 5 | |
#4 | EPO (European Patent Office) | 4 | |
#5 | Australia | 3 | |
#6 | China | 3 | |
#7 | Brazil | 2 | |
#8 | Japan | 1 | |
#9 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Mousa Shaker A | 26 |
#2 | Abdel-Meguid Sherin Salaheldin | 23 |
#3 | Meyers Harold | 19 |
#4 | Elshourbagy Nabil | 19 |
#5 | Meyers Harold V | 9 |
#6 | Elshourbagy Nabil A | 9 |
#7 | Childers Wayne | 7 |
#8 | Martinez Rogelio | 7 |
#9 | Blass Benjamin | 7 |
#10 | Ghidu Victor | 7 |
Publication | Filing date | Title |
---|---|---|
WO2020097016A1 | Anti-proprotein convertase subtilisin kexin type 9 (anti-pcsk9) nano-formulation of compounds and methods of using the same | |
CN109475521A | Anti- 9 type of proprotein convertase subtilisin Kexin (anti-PCSK9) compound and its method for treating and/or preventing cardiovascular disease | |
WO2016205062A1 | Antithrombotic therapies | |
CA2961021A1 | Anti-endothelial lipase compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseases | |
US2015374710A1 | Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseases | |
EP2968318A1 | Anti-pcsk9 compounds and methods for the treatment and/or prevention of cardiovascular diseases | |
AU2014237312A1 | Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseases |